SEC Form 4 · accession 0001235802-16-000295
Wright Medical Group N.V. · WMGI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick Fisher
Officer — President of Lower Extremities
Period of report
Aug 22, 2016
Accepted (ET)
Aug 24, 2016 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492658
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value EUR 0.03 per shareF2 | Aug 22, 2016 | M | 4,000 | $20.75 | A | 42,736 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF3,F2 | Aug 22, 2016 | S | 4,000 | $25.0087 | D | 38,736 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $20.75 | Aug 22, 2016 | M | 4,000 | D | — | May 9, 2022 | Ordinary Shares | 4,000 | 828 | D |
Explanation of responses
- F1The option exercise and sale of shares reported on this Form 4 were effected under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2016.
- F2Includes 15,168 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.01, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- F4This option has fully vested.